Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Adams

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|March 18, 2022
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractilityVolker Adams, Antje Schauer, Antje Augstein, et al.
ESC Heart Failure|December 22, 2020
Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?Keita Goto, Antje Schauer, Antje Augstein, et al.
Circulation. Heart Failure|February 17, 2018
Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume LoopsKarl-Philipp Rommel, Maximilian von Roeder, Christian Oberueck, et al.
Scientific Reports|December 5, 2019
Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial InjuryBernhard Wernly, Georg Fuernau, Maryna Masyuk, et al.
Critical Care (London, England)|December 22, 2014
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialGeorg Fuernau, Janine Pöss, Daniel Denks, et al.
Circulation. Heart Failure|March 15, 2017
Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a BiomarkerChristian Besler, David Lang, Daniel Urban, et al.
ESC Heart Failure|March 26, 2021
Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fractionDavid Bode, Natale P L Rolim, Tim Guthof, et al.
Circulation. Heart Failure|October 6, 2022
Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx TrialEphraim B Winzer, Antje Augstein, Antje Schauer, et al.
Basic Research in Cardiology|October 28, 2009
Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?Viviane M Conraads, Christiaan J Vrints, Inez E Rodrigus, et al.
Journal of the American Heart Association|October 26, 2017
Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection FractionT Scott Bowen, Dominic Brauer, Natale P L Rolim, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Journal of Cachexia, Sarcopenia and Muscle|March 18, 2022
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractilityVolker Adams, Antje Schauer, Antje Augstein, et al.
ESC Heart Failure|December 22, 2020
Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?Keita Goto, Antje Schauer, Antje Augstein, et al.
Circulation. Heart Failure|February 17, 2018
Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume LoopsKarl-Philipp Rommel, Maximilian von Roeder, Christian Oberueck, et al.
Scientific Reports|December 5, 2019
Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial InjuryBernhard Wernly, Georg Fuernau, Maryna Masyuk, et al.
Critical Care (London, England)|December 22, 2014
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialGeorg Fuernau, Janine Pöss, Daniel Denks, et al.
Circulation. Heart Failure|March 15, 2017
Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a BiomarkerChristian Besler, David Lang, Daniel Urban, et al.
ESC Heart Failure|March 26, 2021
Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fractionDavid Bode, Natale P L Rolim, Tim Guthof, et al.
Circulation. Heart Failure|October 6, 2022
Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx TrialEphraim B Winzer, Antje Augstein, Antje Schauer, et al.
Basic Research in Cardiology|October 28, 2009
Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?Viviane M Conraads, Christiaan J Vrints, Inez E Rodrigus, et al.
Journal of the American Heart Association|October 26, 2017
Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection FractionT Scott Bowen, Dominic Brauer, Natale P L Rolim, et al.
Pageof 23